Back to search
Renal Transplant Rejection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Transplant Rejection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Transplant Rejection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who develo…
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years o…
In this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition calle…
The purpose of this open-label, randomized, active-comparator-controlled study is to determine the efficacy and safety of frexalimab subcutaneous administration…
This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.
Induction therapy decreases the rate of acute allograft rejection in kidney transplant recipients (KTRs) and is strongly recommended. Polyclonal lymphocyte-depl…
Assessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"
The goal of this clinical trial is to investigate the physiological and molecular effects of exercise training in transplant recipients. The main questions it a…